Clinical Trial Update: Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating hormone therapy with letrozole in postmenopausal women with breast cancer has completed; the update reports safety and efficacy results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FEMARA (letrozole)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED